Relx Plc (NYSE:RELX) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp increased its position in Relx Plc (NYSE:RELX) by 0.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 249,475 shares of the technology company’s stock after buying an additional 849 shares during the quarter. Bank of New York Mellon Corp’s holdings in Relx were worth $12,576,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of RELX. Ameriprise Financial Inc. raised its position in Relx by 368.7% in the fourth quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company’s stock worth $127,437,000 after acquiring an additional 2,208,119 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Relx by 51.6% in the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company’s stock worth $99,542,000 after purchasing an additional 745,532 shares in the last quarter. GAMMA Investing LLC lifted its stake in Relx by 6,125.5% during the first quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company’s stock valued at $34,232,000 after purchasing an additional 668,165 shares during the last quarter. Bank of Montreal Can boosted its holdings in Relx by 290.3% during the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock worth $40,277,000 after buying an additional 659,547 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in Relx by 50.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock worth $89,420,000 after buying an additional 658,655 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on RELX shares. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They set a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy”.

Relx Price Performance

Shares of NYSE:RELX opened at $52.90 on Monday. The company’s fifty day moving average is $53.65 and its two-hundred day moving average is $51.17. The company has a market cap of $97.16 billion, a P/E ratio of 28.44, a price-to-earnings-growth ratio of 3.45 and a beta of 0.83. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.